Have a personal or library account? Click to login
The equivalence of different types of electric pulses for electrochemotherapy with cisplatin − an in vitro study Cover

The equivalence of different types of electric pulses for electrochemotherapy with cisplatin − an in vitro study

Open Access
|Feb 2024

Abstract

Background

Electrochemotherapy (ECT) is a treatment involving the administration of chemotherapeutics drugs followed by the application of 8 square monopolar pulses of 100 μs duration at a repetition frequency of 1 Hz or 5000 Hz. However, there is increasing interest in using alternative types of pulses for ECT. The use of high-frequency short bipolar pulses has been shown to mitigate pain and muscle contractions. Conversely, the use of millisecond pulses is interesting when combining ECT with gene electrotransfer for the uptake of DNA-encoding proteins that stimulate the immune response with the aim of converting ECT from a local to systemic treatment. Therefore, the aim of this study was to investigate how alternative types of pulses affect the efficiency of the ECT.

Materials and methods

We performed in vitro experiments, exposing Chinese hamster ovary (CHO) cells to conventional ECT pulses, high-frequency bipolar pulses, and millisecond pulses in the presence of different concentrations of cisplatin. We determined cisplatin uptake by inductively coupled plasma mass spectrometry and cisplatin cytotoxicity by the clonogenic assay.

Results

We observed that the three tested types of pulses potentiate the uptake and cytotoxicity of cisplatin in an equivalent manner, provided that the electric field is properly adjusted for each pulse type. Furthermore, we quantified that the number of cisplatin molecules, resulting in the eradication of most cells, was 2−7 × 107 per cell.

Conclusions

High-frequency bipolar pulses and millisecond pulses can potentially be used in ECT to reduce pain and muscle contraction and increase the effect of the immune response in combination with gene electrotransfer, respectively.

DOI: https://doi.org/10.2478/raon-2024-0005 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Language: English
Page range: 51 - 66
Submitted on: Nov 20, 2023
Accepted on: Dec 5, 2023
Published on: Feb 21, 2024
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year

© 2024 Maria Scuderi, Janja Dermol-Cerne, Janez Scancar, Stefan Markovic, Lea Rems, Damijan Miklavcic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.